Establishing Immortalized ILC2 Cell Line for ChIP
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization : Albany Medical Center Hospital
Other organizations : Second Affiliated Hospital of Zhejiang University, University of California, Davis, National Institute of Allergy and Infectious Diseases, National Institutes of Health, National Cancer Institute, Center for Cancer Research, University of Michigan–Ann Arbor
Protocol cited in 2 other protocols
Variable analysis
- Establishment of an immortalized ILC2 line (ILC2/b6) from SiLP ILC2 of C57BL/6 mice by spontaneous mutation and selection
- Characteristics and behavior of the ILC2/b6 cell line
- Maintenance of ILC2/b6 cells with 10ng/ml of IL-2, IL-7 and IL-33
- Growth of ILC2/b6 cells on OP9-Dll1 stroma for CHIP analysis
- Positive control: Not explicitly mentioned
- Negative control: Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!